Australian researchers receive boost with IP reforms

Wednesday, 02 May, 2012

Australian researchers now have the freedom to carry out research without the fear of being sued for patent infringement following the introduction of new laws, according to Parliamentary Secretary for Industry and Innovation Mark Dreyfus.

The new Intellectual Property Laws Amendment (Raising the Bar) Act 2012 sets out these rights in unambiguous language to dispel the uncertainty that has plagued the research sector for years.

“This is a significant development for Australian researchers as they now have clarity around their ability to conduct research without the threat of patent infringement,” Dreyfus said.

“The previous uncertainty discouraged researchers from working in areas where there were pre-existing patents and where they may have been at risk of being sued. Researchers will no longer need to waste time, effort and money on obtaining advice when they have concerns about how their experiments may relate to an existing patent.”

The Raising the Bar Act confirms that researchers are free to undertake research for experimental purposes relating to the subject matter of the invention, as well as:

  • determining the properties of an invention and the scope of its claims;
  • improving or modifying the invention;
  • investigating the validity of a patent or a claim relating to the invention; and
  • examining whether a patent would be or has been infringed.

The reforms exempt experiments carried out after 16 April 2012.

Raising the Bar is the latest in a series of reforms by the Gillard Labor Government, complementing the R&D Tax Incentive introduced last year.

For more information about the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 and the research exemptions, visit IP Australia’s website.

Related News

Vaxxas to advance its microarray patches for COVID vaccination

Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...

Global competition targets 'undruggable' cancer protein

A new global competition offering over US$500,000 in prizes aims to spur drug discovery...

SMi Systems appoints Dr Ankur Mutreja as Senior Advisor

Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd